Company / Return on Assets (ROA)
BioAge Labs, Inc. Return on Assets (ROA) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-27.3%
FY2025
5-year range
-246.3% / -19.9%
FY2023-FY2025
Trend
-37.7%
vs FY2024
Sector context
#122 of 213
Health Care
What the data says
At -27.3%, BioAge Labs, Inc.'s return on assets (roa) ranks #122 of 213 in the Health Care sector. Improved from -246.3% to -27.3% over the past 2 years.
Based on SEC 10-K filings.
-27.3% in FY2025.
Improved from -246.3% to -27.3% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#122 of 213 in Health CareTop 57% of 213This company -27.3% Sector average -24.1%
▼
-13.2% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 37.7% year-over-year.
- Currently 3.2pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -27.3% | -37.7% |
| FY2024 | -19.9% | +91.9% |
| FY2023 | -246.3% | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026